Clinical Trials Browser

Camurati-Engelmann Syndrome × Breast × Clear all

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

NCT03685591 2024-06-26

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Adenocarcinoma, Breast Neoplasms, Carcinoma, Renal Cell, Camurati-Engelmann Syndrome, Liver Neoplasms, Melanoma, Mesothelioma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Neoplasms, Squamous Cell

NCT01401062 2019-03-05

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Phase 2 Completed

23 enrolled 8 charts

Breast

Breast Neoplasms, Camurati-Engelmann Syndrome

NCT01402193 2014-06-25

Study of Arimidex and Radiotherapy Sequencing

Phase 3 Unknown

220 enrolled

Breast

Breast Neoplasms, Camurati-Engelmann Syndrome

NCT00001378 2008-03-04

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

Phase 1 Completed

75 enrolled

Breast

Breast Neoplasms, Camurati-Engelmann Syndrome

Clinical Trials

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Study of Arimidex and Radiotherapy Sequencing

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer